• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Next Steps for Recovery and Rehab

    Scratching the Surface: A Roundtable on Coatings and Treatments

    Influencers on the Orthopedic Implant Manufacturing Market
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Integra LifeSciences Founder Dr. Richard Caruso Passes Away

    FDA Clears CTL Amedica's Navigation Instrument System

    FundamentalVR Raises $20 Million in Series B Funding

    Bioventus Achieves Strong Growth in Q2 2022

    Bone Void Fillers Market Growing at 6%
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    The ODT 2022 Top 10 Orthopedic Device Companies

    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Genetic Risk for Joint Replacement Failure

    The Case for Using Historical Control in Clinical Trial Design
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Orthopedic Device Evolution is Driven by Precision Technology

    mdHACM Allografts Demonstrate Potential in Treating Knee Osteoarthritis

    Radically Improving Medicine & Surgery with Light Field Technology

    A Call to Action in Orthopedics: We Need to Personalize Every Single Hip and Knee Surgery

    Giving Knee Replacement Surgery a Much-Needed Update
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Tiodize

    Modern Plastics

    Life Science Outsourcing Inc.

    AV&R

    Braxton Manufacturing
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    EU MDR Interpretation and Understanding—Devil in the Details

    While the date to conform to all transitional requirements has passed, a new wave of scrutiny will arrive as organizations seek certification under the new MDR.

    EU MDR Interpretation and Understanding—Devil in the Details
    Bryan Brosseau, Founder and Principal Consultant, Brosseau Consulting LLC11.17.21
    The application date for Regulation (EU) 2017/745 (EU MDR) has passed and medtech organizations are realizing that May 24, 2024 (or an even earlier MDD certificate expiration date) is drawing near. While the date to conform to all transitional requirements has passed, a new wave of scrutiny will arrive as organizations seek certification under the new MDR. In recent conversations with industry colleagues and Notified Body personnel, it seems that one of the most challenging conformance aspects is interpreting the new regulations and understanding their practical application.

    Incorporating regulatory requirements into a quality management system (QMS) depends on interpreting and fully understanding MDR mandates. In some cases, the new requirements are clearly and objectively defined, leaving little room for interpretation. For example, Article 15 states that manufacturers must have at least one employee responsible for regulatory compliance with defined criteria for that person’s qualification (e.g., “four years of professional experience in regulatory affairs or in quality management systems relating to medical devices” or a combination of one year of comparable experience and a relevant university degree). Such details leave little to guesswork.

    In other cases, the regulation as written is not as clearly defined. For example, Paragraph 5 of Article 61 contains a new requirement that is making medtech manufacturers of various device classifications very anxious. Article 61 states that when equivalence is used to leverage clinical data from another manufacturer’s device instead of a study, “the two manufacturers have a contract in place that explicitly allows the manufacturer of the second device full access to the technical documentation on an ongoing basis.” Some creators of Class IIa devices that previously claimed equivalence to similar products have misunderstood this requirement. They panicked upon hearing a grossly simplified interpretation of the regulation: “you claim equivalence to a similar product, you now must have a contract with that manufacturer.” However, this is not the case, as clinical investigation is now required only for Class IIb and III devices. Additionally, this principal does not apply to all equivalence claims for clinical evaluation. Part A of Annex XIV requires, “manufacturers have sufficient levels of access to data relating to devices with which they are claiming equivalence in order to justify their claims of equivalence.” But it should be noted that no agreement is explicitly required—the new regulation only mandates such an agreement when leveraging clinical data for the equivalent device instead of a study. It is feasible to perform an evaluation using clinical literature for the equivalent device and comparative analysis or testing of the device, provided the manufacturer has the necessary data for which equivalence is claimed through testing or from some other source.

    Further to the available requirements, new common specification documents or other, applicable regulations (e.g., 1272/2008/EEC) are subject to interpretation and understanding by staff handling the transition. Looking forward, delegating and implementing acts may also present such opportunities. There is a lot to digest and only so much time to do so. There are several practices that may expedite compliance and influence an efficient and thorough adoption of MDR requirements into the QMS and technical documentation.

    Incorporating MDR requirements into QMS and technical documentation entails several steps for an efficient transition, including a) accurately interpreting the MDR text and ensuring an understanding, b) assessing existing information for the device, and c) formulating the appropriate path forward to leverage existing information or obtain new supporting data.

    To begin, companies must step back and consider all relevant aspects of the regulation to interpret this requirement. In particular, they should search the regulation for any related content that may give clues to the EU Commission’s intent. For example, whereas most content regarding the Summary of Safety and Clinical Performance is in Article 32, there is also information that may drive interpretation in Paragraph 49 and Article 61.

    Other sources to help companies interpret and apply MDR requirements follow.

    MDCG guidance documents: New documents are released frequently, and many have already been released for device classification, UDI (Unique Device Identification), Clinical Investigation and Evaluation, PRRC (Person Responsible for Regulatory Compliance), and implant cards. MDCG guidance documents for Notified Bodies also should be reviewed, as they clarify MDR content as well as the Notified Bodies’ role in auditing the QMS and assessing technical documentation. Consult the Europa website for a complete list of published guidance and list of guidance documents in progress.1

    Education: Healthcare executives should attend MDR-related conferences, virtual events, training, or seminars. These not only can bolster knowledge of the MDR but address the increased regulatory focus on competence. Documentation of such events can supplement companies’ audit preparedness and consultants’ qualifications as a supplier by clients. Before committing to a conference, however, participants should review the agenda and the speaker biographies. Attending an event with speakers from regulatory agencies and notified bodies allows participants to obtain information directly from the authorities and provides networking opportunities with these professionals. Speakers with experience in multiple organizations, with therapies, or obtaining certification of various technologies also brings ideal perspective for understanding and applying MDR requirements.

    Networking: While an informal network may be susceptible to erroneous information compared to the resources previously mentioned, sometimes posing a question to a professional network is an effective way to quickly vet an idea. Understanding how colleagues’ companies are addressing the requirements is a valid means of assessing the landscape—the same landscape Notified Bodies are auditing and certifying daily. Specifically, companies should consider “tried and true” methods that have withstood the rigor of MDR certification.  As more organizations achieve certification, the availability of such examples will increase.

    Existing QMS and technical documentation: Medtech firms should not completely write off existing documentation simply because it wasn’t compiled under the MDR. Consider what sources were leveraged in creating the documentation. In several instances, new requirements under the MDR are not new concepts. For example, many organizations are implementing procedures for trend reporting for the first time, while other are simply adapting existing procedures. Although the MDD did not include the same requirement for trend reporting as the MDR, this topic has been addressed in MEDDEV 2 12-1 rev. 82 and GHTF SG2 document N36 “Manufacturer’s Trend Reporting of Adverse Events”3 since 2013 and 2003, respectively. As such, some QMS are already primed for some MDR requirements.

    Gap analysis: A gap analysis of current QMS and technical documentation is critical in interpreting the regulation considering an organization’s historical system and information under the MDD. Even in cases where a gap analysis has been performed, more detailed and focused gap analyses on specific elements of the QMS is helpful in elucidating mandates where a broad gap analysis was completed by staff who were diving into the MDR for the first time. The participation of subject matter experts in this detailed assessment is critical in understanding and applying the new requirements.

    Publications and white papers: There are numerous sources of digital information that help with interpreting, understanding, and applying MDR requirements. Many trusted consulting organizations, industry publications, and even Notified Bodies provide helpful information through articles, whitepapers, social media content, and infographics that simplify MDR content.

    Notified Bodies: Besides publicly available documents, many Notified Bodies have sought to flatten the learning curve for clients by providing information that does not cross the line into prohibited consulting. Such information takes the form of Notified Body policy, forms or templates, and informal feedback during audits and reviews. Companies should consider asking the Notified Body what policy, forms, or other information they have that should be considered in complying with the MDR.

    EUDAMED: The increased requirement for publicly available safety and performance information also results in a potential reference point for organizations that have not yet uploaded such information to EUDAMED. As EUDAMED modules are released, such examples will be available for all to see.4 For example, Summaries of Safety and Clinical Performance (SSCP) will be published for implantable and Class III devices. As of early October, the device module is live with device listings for two manufacturers (albeit no devices yet which require the SSCP). 

    References
    1. bit.ly/3wrwpnW
    2. bit.ly/3qj7lOV
    3. bit.ly/3wtErwH
    4. bit.ly/3kifGih


    Bryan Brosseau’s experience has been forged in 20 years in the medical device and biologics industries. With a varied and in-depth knowledge of quality and regulatory requirements, he drives quality and compliance without impeding progress. Bryan implements, manages, and improves quality management systems for numerous companies and has obtained regulatory approvals for products across a wide range of therapy areas. Bryan received his bachelor’s degree in biology from the University of Georgia, maintains a Regulatory Affairs Certification (U.S.) from the Regulatory Affairs Professionals Society, and is a certified ISO 13485:2016 and MDSAP Lead Auditor.
    Loading, Please Wait..

    Trending
    • MdHACM Allografts Demonstrate Potential In Treating Knee Osteoarthritis
    • Additive Manufacturing At The Point Of Care
    • Bioventus Launches DUROLANE In The U.S.
    • FundamentalVR Raises $20 Million In Series B Funding
    • Future Stars Of The Spine Industry: The Companies To Watch, 2021
    Breaking News
    • Integra LifeSciences Founder Dr. Richard Caruso Passes Away
    • FDA Clears CTL Amedica's Navigation Instrument System
    • FundamentalVR Raises $20 Million in Series B Funding
    • Bioventus Achieves Strong Growth in Q2 2022
    • Bone Void Fillers Market Growing at 6%
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Additive Manufacturing at the Point of Care
    • Six Orthopedic Firms En Route to Significant Market Disruption
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression
    Coatings World

    Latest Breaking News From Coatings World

    The BEHR & KILZ Brands Partner with Leanne Ford to Revitalize Her Historic American Home
    IGM Resins Acquires Litian
    Ingevity to Acquire Pavement Marking Materials Business, Ozark Materials
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    TransMed7 Achieves First-in-Human for Heron Soft Tissue Biopsy Devices
    West Pharmaceutical Services Invests in Latch Medical
    Integra LifeSciences Founder Dr. Richard Caruso Passes Away
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Societal CDMO Inks Land Sell Deal
    RoosterBio and AGC Biologics to Accelerate Manufacturing of Cell and Exosome Therapies
    WuXi Advanced Therapies Enters Licensing Agreement with Janssen
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Johnson & Johnson to Discontinue Global Sales of Talc-Based Baby Powder
    Dr. Squatch To Launch a 2nd Star Wars Soap Collection
    Neopac Wins 2 European Tube Manufacturers Association Awards
    Happi

    Latest Breaking News From Happi

    Nutrafol Launches Vegan Microbiome-Boosting Strand Defender Conditioner
    Climate Change Drives Sustainability in Household & Personal Care
    Japonesque Acquires Foot Care Brand Barefoot Scientist
    Ink World

    Latest Breaking News From Ink World

    Leadership Change in ALTANA’s ELANTAS Division
    Nazdar Highlights Ink Innovation at Labelexpo Americas 2022
    Cyngient, Imageworx Partner at Labelexpo for Security Labeling
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI partners with Convergen Energy at Labelexpo
    FINAT reports decrease in labelstock consumption during first half of 2022
    Color-Logic partners to feature metallics at autumn events
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Because Market Expands into Retail Stores
    Tranzonic Acquired by Private Investment Firm
    Monadnock Earns EcoVadis Gold Rating
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Integra LifeSciences Founder Dr. Richard Caruso Passes Away
    FDA Clears CTL Amedica's Navigation Instrument System
    FundamentalVR Raises $20 Million in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints John Cooney to Lead Global Advocacy and Public Policy
    NMBS/SNCB Improves Security With HID Global’s Real-Time Location Service Technology
    onsemi Celebrates Expansion of Silicon Carbide Production Facility in New Hampshire

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login